Eton Pharmaceuticals, Inc. (NASDAQ:ETON) has 101 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 31 Dec, 2025 | 2,860,000 | 0 | 0.00% | $48,362,600.00 |
| EcoR1 Capital, LLC | 31 Dec, 2025 | 2,030,544 | 0 | 0.00% | $34,336,499.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 1,738,907 | 34,546 | 2.03% | $29,404,917.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,348,668 | 4,553 | 0.34% | $22,805,976.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 1,175,951 | 0 | 0.00% | $19,885,331.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 565,051 | -8,979 | -1.56% | $9,557,084.00 |
| State Street Corp | 31 Dec, 2025 | 501,925 | 63,480 | 14.48% | $8,487,552.00 |
| Morgan Stanley | 31 Dec, 2025 | 493,914 | -92,132 | -15.72% | $8,352,085.00 |
| Westside Investment Management, Inc. | 31 Dec, 2025 | 470,940 | -1,600 | -0.34% | $7,963,285.00 |
| OBERWEIS ASSET MANAGEMENT INC/ | 31 Dec, 2025 | 431,300 | 238,940 | 124.22% | $7,293,283.00 |
| THOMPSON SIEGEL & WALMSLEY LLC | 31 Dec, 2025 | 408,541 | -10,025 | -2.40% | $6,908.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 392,526 | 202,362 | 106.41% | $6,637,614.00 |
| Aristides Capital LLC | 31 Dec, 2025 | 322,872 | 155,285 | 92.66% | $5,459,766.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Dec, 2025 | 277,458 | 47,668 | 20.74% | $4,691,815.00 |
| Northern Trust Corp | 31 Dec, 2025 | 231,849 | -13,202 | -5.39% | $3,920,566.00 |
| CANNELL CAPITAL LLC | 31 Dec, 2025 | 216,917 | -238,488 | -52.37% | $3,668,066.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 205,700 | -118,921 | -36.63% | $3,478,387.00 |
| Diametric Capital, LP | 31 Dec, 2025 | 193,155 | 93,846 | 94.50% | $3,266,251.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 185,439 | -517,395 | -73.62% | $3,135,773.00 |
| Lumbard & Kellner, LLC | 31 Dec, 2025 | 174,944 | -1,356 | -0.77% | $2,958,303.00 |